Detalhe da pesquisa
1.
Another Victory for Patients with Hemophilia.
N Engl J Med
; 388(4): 372-373, 2023 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36720139
2.
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.
Haemophilia
; 27(6): 911-920, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614267
3.
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.
Haemophilia
; 27(6): 921-931, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636112
4.
The evolution of factor VIIa in the treatment of bleeding in haemophilia with inhibitors.
Haemophilia
; 25(6): 911-918, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31489759
5.
Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes.
Haemophilia
; 25(5): 867-875, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31115111
6.
Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.
Blood
; 127(20): 2481-8, 2016 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26862110
7.
How I use bypassing therapy for prophylaxis in patients with hemophilia A and inhibitors.
Blood
; 126(2): 153-9, 2015 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25827834
8.
Acquired hemophilia A: Updated review of evidence and treatment guidance.
Am J Hematol
; 92(7): 695-705, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28470674
9.
Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia.
Am J Hematol
; 92(8): 730-738, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28388835
10.
A Model for Predicting Persistent Elevation of Factor VIII among Patients with Acute Ischemic Stroke.
J Stroke Cerebrovasc Dis
; 25(2): 428-35, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26777556
11.
No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation.
Blood
; 121(18): 3742-4, 2013 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23520336
12.
Use of Factor XIII (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures.
Transfusion
; 55(1): 45-50, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25070582
13.
Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening.
Am J Hematol
; 90(10): 871-6, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26147783
14.
Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors.
N Engl J Med
; 365(18): 1684-92, 2011 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22047559
15.
VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.
Blood
; 119(9): 2135-40, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22197721
16.
Why plasma-derived factor VIII?
Haemophilia
; 25(3): e183-e185, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30866124
17.
Dose of prophylactic platelet transfusions and prevention of hemorrhage.
N Engl J Med
; 362(7): 600-13, 2010 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-20164484
18.
Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.
Blood
; 116(2): 280-6, 2010 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20231421
19.
The literature on inhibitors: articles that influence my management of patients with hemophilia A and high-titer inhibitors.
Am J Hematol
; 87 Suppl 1: S23-6, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22473571
20.
Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life.
J Adv Pract Oncol
; 13(Suppl 3): 7-20, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35769336